BioSpace News Archive

Stallergenes Greer announced that house dust mite induced allergic rhinitis, its treatment with sublingual tablets and the benefits of allergen immunotherapy for patients will be presented at the annual EAACI Congress to be held in Lisbon from June 1-5 2019.

Exact Sciences Corp. announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast.

Rakuten Medical, a clinical-stage biotechnology company developing precision-targeted cancer therapies based on its proprietary photoimmunotherapy platform, has established new office locations in both Amsterdam, Netherlands and Taipei, Taiwan to further strengthen its position in these geographic areas.

Witty Health Inc., an oncology-focused digital health company has announced the release of Prescription Drug- Use Related Software services on OncoPower, an oncologist-designed platform that utilizes digital health and professional networking to improve cancer care and precision medicine.

Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in All Patient Populations (Regardless of PD-L1 Expression) and with KEYTRUDA Monotherapy in Patients Whose Tumors Expressed PD-L1 at CPS ≥1

Shipping powered protection for patients and iPhones®

The Seattle Sperm Bank announces the opening of its 3rd laboratory location, at 8950 Villa La Jolla Drive, Suite B214, La Jolla, CA 92037.

Data-driven food allergy diagnostics company, AllerGenis, LLC today announced its activities at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2019 being held from June 1st through 5th in Lisbon, Portugal, with the theme of bringing precision medicine into the field of allergy and clinical immunology.

bluebird bio, Inc. announced that the Company will hold a conference call to discuss data presented at the European Hematology Association Annual Meeting on Friday, June 14 at 8:00 am ET.

Goldfinch Bio, Inc. announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will present at the following investor conferences in June: